跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,629 条关于
“SCN8A epilepsy”
全部
2,629
临床试验
2,091
药物
51
机构
9
资讯
478
10个月前
Praxis Precision Medicines Advances Multiple Neurological Programs Following Essential Tremor Success
2年前
Relutrigine Shows Promise in Reducing Seizures in SCN2A/SCN8A-DEE Phase 2 Trial
9个月前
Praxis Precision Medicines to Showcase Epilepsy Pipeline at AES 2025 with Full RADIANT Study Results
去年
Praxis Precision Medicines Presents Promising Epilepsy Pipeline Updates at AES 2024
去年
FDA Grants Rare Pediatric Disease Designation to Praxis' Relutrigine for Dravet Syndrome
9个月前
Praxis Precision Medicines Reports Positive EMBOLD Study Results for Relutrigine in Rare Epileptic Encephalopathies
2年前
Insights into Long COVID's Neurological Impact, MS Progression, and SCN8A-Related Disorders
去年
Praxis Precision Medicines Announces Strategic Priorities and Pipeline Milestones for 2025
去年
Praxis Precision Medicines Advances CNS Pipeline with Key Clinical Milestones
去年
Praxis Precision Medicines Advances Pipeline with Relutrigine into Late-Stage Development
第 1 页,共 48 页
上一页
下一页